[go: up one dir, main page]

RO82216B - Procedeu pentru prepararea unor derivati ai 3-aril-5-izotiazolului - Google Patents

Procedeu pentru prepararea unor derivati ai 3-aril-5-izotiazolului

Info

Publication number
RO82216B
RO82216B RO105346A RO10534681A RO82216B RO 82216 B RO82216 B RO 82216B RO 105346 A RO105346 A RO 105346A RO 10534681 A RO10534681 A RO 10534681A RO 82216 B RO82216 B RO 82216B
Authority
RO
Romania
Prior art keywords
carbon atoms
general formula
aryl
hydrogen
preparation
Prior art date
Application number
RO105346A
Other languages
English (en)
Other versions
RO82216A (ro
Inventor
James Richard Beck
Robert Peter Gajewski
Ronald Ervin Hackler
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of RO82216B publication Critical patent/RO82216B/ro
Publication of RO82216A publication Critical patent/RO82216A/ro

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Inventia se refera la un procedeu pentru prepararea unor derivati ai 3-aril-5-izotiazolului cu formula generala I: (vezi formula) în care R reprezinta hidrogen, halogen, o grupa amino, hidroxi sai alchilamino cu 1...4 atomi de carbon Ar reprezinta fenil, piridil, tienil sau: (vezi formula) în care R1, R2 si R3 reprezinta hidrogen, halogen, grupe haloalchil cu 1...4 atomi de carbon, alcoxi cu 1...4 atomi de carbon, alchil cu 1...4 atomi de carbon, sau R1 si R2 si R3 luati împreuna reprezinta un radical alchilendioxi cu 1...4 atomi de carbon cu exceptia cazului în care R reprezinta hidrogen sau brom, si Ar reprezinta fenil, constînd din aceea ca un compus cu formula generala II: (vezi formula) în care R si Ar au semnificatiile de mai sus si Qreprezinta un radical ales dintre (vezi formula) în care R4 si R5 sunt identici sau diferiti si reprezinta hidrogen sau alchil cu 1...3 atomi de carbon si R6 reprezinta alchil cu 1...4 atomi de carbon se hidrolizeaza în prezenta unui hidroxid de met al alcalin, în mediu apos, la o temperatura cuprinsa între 0 si 110 degree C, iar acidul cu formula generala I poate fi, eventual, transformat, prin metode în sine cunoscute, într-o sare sau ester acceptabile farmaceutic.
RO81105346A 1980-09-22 1981-09-21 Procedeu pentru prepararea unor derivati ai 3-aril-5-izotiazolului RO82216A (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/189,435 US4346094A (en) 1980-09-22 1980-09-22 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels

Publications (2)

Publication Number Publication Date
RO82216B true RO82216B (ro) 1983-06-30
RO82216A RO82216A (ro) 1983-07-07

Family

ID=22697314

Family Applications (1)

Application Number Title Priority Date Filing Date
RO81105346A RO82216A (ro) 1980-09-22 1981-09-21 Procedeu pentru prepararea unor derivati ai 3-aril-5-izotiazolului

Country Status (22)

Country Link
US (1) US4346094A (ro)
EP (1) EP0048615B1 (ro)
JP (1) JPS5785379A (ro)
KR (1) KR830007597A (ro)
AR (1) AR229103A1 (ro)
AT (1) ATE7657T1 (ro)
AU (1) AU7551681A (ro)
CS (1) CS228536B2 (ro)
DD (1) DD201790A5 (ro)
DE (1) DE3163900D1 (ro)
DK (1) DK417981A (ro)
ES (1) ES8301225A1 (ro)
FI (1) FI812940L (ro)
GB (1) GB2084573B (ro)
GR (1) GR75046B (ro)
IL (1) IL63890A0 (ro)
NO (1) NO813208L (ro)
PL (1) PL130497B1 (ro)
PT (1) PT73711B (ro)
RO (1) RO82216A (ro)
YU (1) YU227181A (ro)
ZA (1) ZA816549B (ro)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428956A (en) 1980-12-29 1984-01-31 Merck & Co., Inc. 4-Hydroxy-5-substituted-3-(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis
US4431652A (en) * 1980-12-29 1984-02-14 Merck & Co., Inc. 4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis
US4539328A (en) * 1983-03-25 1985-09-03 Fmc Corporation Nematicidal isothiazole derivatives
US4620865A (en) * 1983-11-07 1986-11-04 Eli Lilly And Company Herbicidal and algicidal 1,5-disubstituted-1H-pyrazole-4-carboxamides
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
ZW21687A1 (en) * 1986-12-12 1988-07-20 Hoffmann La Roche Triazine derivatives
SG86971A1 (en) * 1990-11-30 2002-03-19 Teijin Ltd 2-arylthiazole derivatives and pharmaceutical composition thereof
US5294630A (en) * 1992-07-07 1994-03-15 Eli Lilly And Company Treatment of inflammatory bowel disease
US5436258A (en) * 1992-09-09 1995-07-25 Eli Lilly And Company Prevention of bone resorption
MY117352A (en) * 1995-10-31 2004-06-30 Ciba Sc Holding Ag Oximesulfonic acid esters and the use thereof as latent sulfonic acids.
ID21775A (id) * 1996-10-25 1999-07-22 Yoshitomi Pharmaceutical Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
AU1520699A (en) * 1997-11-07 1999-05-31 Johns Hopkins University, The Methods for treatment of disorders of cardiac contractility
TW575792B (en) * 1998-08-19 2004-02-11 Ciba Sc Holding Ag New unsaturated oxime derivatives and the use thereof as latent acids
SG78412A1 (en) 1999-03-31 2001-02-20 Ciba Sc Holding Ag Oxime derivatives and the use thereof as latent acids
WO2003067332A2 (en) 2002-02-06 2003-08-14 Ciba Specialty Chemicals Holding Inc. Sulfonate derivatives and the use therof as latent acids
US7612108B2 (en) * 2004-08-27 2009-11-03 Astellas Pharma Inc. 2-phenylthiophene derivative
MX2007002160A (es) * 2004-08-27 2007-05-10 Astellas Pharma Inc Derivado de 2-fenilpiridina.
JP5040656B2 (ja) 2005-10-07 2012-10-03 アステラス製薬株式会社 トリアリールカルボン酸誘導体
PL1992361T3 (pl) 2006-02-24 2012-10-31 Astellas Pharma Inc Środek do leczenia lub zapobiegania wrzodowi trawiennemu
GB2450975B (en) 2007-07-12 2010-02-24 Ciba Holding Inc Yellow radiation curing inks
MX2010012656A (es) * 2008-05-22 2010-12-20 Squibb Bristol Myers Co Metodo para tratar la hiperuricemia empleando un inhibidor de sglt2 y composicion que contiene el mismo.
CN102333765B (zh) 2009-02-27 2015-01-14 帝人制药株式会社 基于使用过渡金属催化剂的偶联法的苯基取代杂环衍生物的制造方法
KR20110137821A (ko) 2009-03-30 2011-12-23 바스프 에스이 Uv-조사량 인디케이터 필름
PL2610248T3 (pl) 2010-08-27 2016-12-30 Sposób wytwarzania podstawionych fenylem pochodnych heterocyklicznych metodą sprzęgania z użyciem związku palladu
WO2012101245A1 (en) 2011-01-28 2012-08-02 Basf Se Polymerizable composition comprising an oxime sulfonate as thermal curing agent
BR112015024462A2 (pt) 2013-03-29 2017-07-18 Teijin Pharma Ltd composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor da xantina oxidase, e, agente terapêutico ou profilático para uma doença
WO2016030790A1 (en) 2014-08-29 2016-03-03 Basf Se Oxime sulfonate derivatives
BR112017023170B1 (pt) 2015-04-29 2022-08-16 Bsn Medical Gmbh Dispositivo de banho medicinal e seu uso
CN107809996A (zh) 2015-04-29 2018-03-16 Bsn医疗有限公司 一氧化氮产生的多步骤方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1178604A (en) * 1966-03-21 1970-01-21 American Cyanamid Co Novel Pyridinium Salts and Methods for Preparing Same
US3464999A (en) * 1967-07-27 1969-09-02 R & L Molecular Research Ltd Thiadiazolylisothiazoles
GB1180268A (en) * 1967-09-26 1970-02-04 Ici Ltd Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives
GB1192701A (en) * 1968-03-22 1970-05-20 Ici Ltd Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same
US3681498A (en) * 1970-10-19 1972-08-01 American Cyanamid Co Isothiazolyl pyridinium salts as hypoglycemic agents

Also Published As

Publication number Publication date
KR830007597A (ko) 1983-11-04
ZA816549B (en) 1983-04-27
IL63890A0 (en) 1981-12-31
GR75046B (ro) 1984-07-12
AR229103A1 (es) 1983-06-15
PT73711B (en) 1982-12-20
FI812940A7 (fi) 1982-03-23
YU227181A (en) 1983-10-31
PT73711A (en) 1981-10-01
ES505678A0 (es) 1982-12-01
PL233103A1 (ro) 1982-12-20
DK417981A (da) 1982-03-23
EP0048615B1 (en) 1984-05-30
US4346094A (en) 1982-08-24
ATE7657T1 (de) 1984-06-15
CS228536B2 (en) 1984-05-14
NO813208L (no) 1982-03-23
JPS5785379A (en) 1982-05-28
AU7551681A (en) 1982-04-01
FI812940L (fi) 1982-03-23
GB2084573A (en) 1982-04-15
PL130497B1 (en) 1984-08-31
ES8301225A1 (es) 1982-12-01
DE3163900D1 (en) 1984-07-05
EP0048615A1 (en) 1982-03-31
GB2084573B (en) 1984-09-12
DD201790A5 (de) 1983-08-10
RO82216A (ro) 1983-07-07

Similar Documents

Publication Publication Date Title
RO82216B (ro) Procedeu pentru prepararea unor derivati ai 3-aril-5-izotiazolului
RO70660B (ro) Procedeu pentru prepararea unor derivati de 3-arilo0i-3-fenilpropilamina
ES2000910A6 (es) Procedimiento para preparar piridina-2,3-dicarboxilatos sustituidos y disustituidos
RO70264B (ro) Procedeu pentru prepararea unor derivati ai acidului 1-alchil-5-aroilpirol-2-acetic
RO82962B (ro) Procedeu pentru prepararea unor derivati de cefalosporina
RO83311B (ro) Procedeu de preparare a unor saruri de monoester de acid fosforic
RO80036B (ro) Procedeu pentru obtinerea unor derivati ai n-tiolcarbonil n-fosfonometilglicinei
RO86851B (ro) Procedeu pentru prepararea unor derivati de piperazin-2-ona
RO82173B (ro) Procedeu de obtinere a unor derivati de flavan
NO840595L (no) Fremgangsmaate ved fremstilling av nye carbacycliner
ZA847673B (en) Quinazoline and isoquiniline derivatives
AU579116B2 (en) Use of quinoline derivatives for the protection of cultivated plants
RO84586B (ro) Procedeu pentru prepararea unor derivati de piranona
PL281367A1 (en) Method of obtaining novel purine derivatives
RO85556B (ro) Procedeu pentru prepararea unor derivati de aminoacizi
RO83707B (ro) Procedeu pentru prepararea esterilor clormetilici ai unor derivati ai acidului penicilanic
GB1397647A (en) Thiophene derivatives
RO81506B (ro) Procedeu pentru prepararea derivati de acizi 1, 3, 4-tiadiazol-2-carboxilici
RO83468B (ro) Procedeu de obtinere a derivatilor de 5, 6, 7, 7a-tetrahidro-4h-tieno(3, 2-c)-piridin-2-onei
FI822133L (fi) Nya 1-benzyl-3,4-dihydro-isokinolinderivat
ES8301931A1 (es) Un procedimiento para la preparacion de nuevos imidazoles.
RO81937B (ro) Procedeu pentru prepararea unor derivati ai acidului 7 beta - aminotiazolil -acetamido-3-cefem-4-carboxilic
RO85820B (ro) Procedeu pentru prepararea unor derivati de metil-chinoxalin-1, 4-dioxid
RO86840B (ro) Procedeu de preparare a unor esteri ai acidului fenoxifenoxipropioni cu proprietati erbicide
RO67533B (ro) Procedeu pentru prepararea unor derivati de 3-triaziniltiometilcefalosporina